4//SEC Filing
Eade Katherine A. 4
Accession 0001437749-23-018537
CIK 0001851657other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:35 PM ET
Size
5.7 KB
Accession
0001437749-23-018537
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Eade Katherine A.
Director
Transactions
- Award
Stock option (right to buy)
2023-06-20+132,352→ 132,352 totalExercise: $2.21→ Class A common stock (132,352 underlying)
Footnotes (3)
- [F1]These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation.
- [F2]These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the Issuer through the vesting date.
- [F3]These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates.
Documents
Issuer
Vaxxinity, Inc.
CIK 0001851657
Entity typeother
Related Parties
1- filerCIK 0001721318
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 6:35 PM ET
- Size
- 5.7 KB